HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
HITI
High Tide Inc.
HITI lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
HITI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Under pressure | |
| Weak |
HITI's revenue is currently strong, but its profitability, cash flow and balance sheet are under pressure.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
HITI PE Valuation
HITI has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
HITI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
HITI has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has the edge over HITI on earnings, with more consistent year-over-year improvement.
HITI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.27 | -$0.22 |
| Q2 2026 | -$0.35 | -$0.30 |
| Q1 2026 | -$0.38 | -$0.36 |
| Q4 2025 | -$0.41 | -$0.41 |
| Q4 2024 | -$0.00 | +$0.37 |
| Q4 2023 | -$0.37 | +$0.38 |
| Q3 2023 | -$0.60 | -$0.31 |
| Q2 2023 | -$0.60 | -$0.32 |
HITI is still losing money, but far less than before: $0.27 per share over the past year, against $1.38 at its worst in early 2020.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over HITI on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
HITI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $141.3M | +34% |
| Q2 2026 | $126.1M | +30% |
| Q1 2026 | $125.6M | +25% |
| Q4 2025 | $115.3M | +19% |
| Q3 2025 | $105.2M | +14% |
| Q2 2025 | $96.9M | +11% |
| Q1 2025 | $100.2M | +11% |
| Q4 2024 | $97.2M | +8.8% |
HITI's revenue has grown year over year every quarter since early 2021: $141M last quarter, up 34% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.3% | +1.8 points |
| Q2 2026 | 4.5% | +3.8 points |
| Q1 2026 | 2.3% | +2.3 points |
| Q4 2025 | -12% | -9.6 points |
| Q3 2025 | 2.5% | +0.2 points |
| Q2 2025 | 0.7% | -0.9 points |
| Q1 2025 | 0.1% | -2.1 points |
| Q4 2024 | -2% | N/A |
HITI has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over HITI on cash flow, with more consistent year-over-year improvement.
HITI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.5M | +10% |
| Q2 2026 | $1.6M | -59% |
| Q1 2026 | $2.2M | +$3.7M |
| Q4 2025 | $812.7K | -85% |
| Q3 2025 | $5.9M | +206% |
| Q2 2025 | $4M | -46% |
| Q1 2025 | -$1.4M | -143% |
| Q4 2024 | $5.4M | +2.4% |
HITI still generates free cash flow, though less than at its 2024 peak: $11M over the past year.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over HITI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
HITI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +7.6% | +6.7M shares |
| 1 year | +6.8% | +6M shares |
| 3 years | +26% | +19.6M shares |
| 5 years | +96% | +46.2M shares |
| Available history | +672% | +82.3M shares |
HITI has 95M diluted shares, up 6.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
HITI hasn't bought back shares in the past year.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
HITI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 17.4x | High |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 1.0x | Healthy |
| Q1 2025 | 1.1x | Healthy |
| Q4 2024 | 0.8x | Very low |
| Q3 2022 | 5.6x | High |
| Q2 2022 | 5.1x | High |
| Q1 2022 | 7.5x | High |
HITI's net debt is about 17 years of its operating earnings (EBITDA), up from less than a year a year ago.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
HITI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.0 | Neutral |
| Stochastic | 59.7 | Neutral |
HITI's weekly RSI is 50 (neutral) and its Stochastic is 60 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
HITI PE vs Healthcare Sector
HITI has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
HITI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.61 | 4.2% below |
| 20 week MA | $2.46 | 1.6% above |
| 50 week MA | $2.46 | 1.6% above |
| 100 week MA | $2.59 | 3.5% below |
| 200 week MA | $2.20 | 14% above |
HITI has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
HITI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $3.15 | $4.70 | +49% |
| 2022 | $4.70 | $1.43 | -70% |
| 2023 | $1.43 | $1.63 | +14% |
| 2024 | $1.63 | $3.05 | +87% |
| 2025 | $3.05 | $2.78 | -8.9% |
| 2026 YTD | $2.78 | $2.50 | -10% |
HITI has the edge over HIMS on returns for 2026, with the stronger performance.